IP48-11: European Commission 2019 fluoroquinolone restrictions: difference-in-differences shows Poland’s excess defined daily doses versus the European Union/European Economic Area without short-term Escherichia coli resistance benefit

IP48-11: European Commission 2019 fluoroquinolone restrictions: difference-in-differences shows Poland’s excess defined daily doses versus the European Union/European Economic Area without short-term Escherichia coli resistance benefit

Saturday, May 16, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)

147B

Abstract

Sessions

IP48: Infections/Inflammation/Cystic Disease of the Genitourinary Tract: Kidney & Bladder II

Saturday, May 16, 2026 3:30 PM to 5:30 PM

Log in

See all the content and easy-to-use features by logging in or registering!